Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Next AdvaMed Chief Is BIO Exec Scott Whitaker

This article was originally published in The Gray Sheet

Executive Summary

Whitaker, appointed as the next CEO of AdvaMed, currently runs day-to-day operations at the Biotechnology Innovation Organization and has held high-level posts at HHS. Among his accomplishments, Whitaker led the legislative office at HHS when the first device user fee bill was passed in 2002.


Related Content

Q&A With Scott Whitaker: AdvaMed's Next CEO On The Path Ahead
FDA, Industry Agree On Working Groups To Support User-Fee Negotiations
Senate Will Tackle Separate Device Reform Bills As Part Of Innovation Agenda
Breakthrough Reimbursement Proposals Percolate From FDA, Industry
AdvaMed Launches National Search For New CEO As Ubl Plans Departure
BIO Plans Lobbying Push To Improve Payments For Diagnostics
AdvaMed Aims To Make A Splash In D.C. At First Annual Conference





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts